Diabetic Subjects Diagnosed Through the Diabetes Prevention Trial–Type 1 (DPT-1) Are Often Asymptomatic With Normal A1C at Diabetes Onset
Open Access
- 1 May 2009
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (5), 769-773
- https://doi.org/10.2337/dc08-1872
Abstract
OBJECTIVE: Upon diagnosis of type 1 diabetes, patients are usually symptomatic, and many have ketoacidosis. Screening for islet autoantibodies (IAs) has been shown to decrease A1C level and rate of hospitalization at diabetes onset. Metabolic tests and the presence of symptoms were described at diabetes onset during the Diabetes Prevention Trial–Type 1 (DPT-1). RESEARCH DESIGN AND METHODS: The DPT-1 screened relatives of patients with type 1 diabetes for islet cell autoantiobodies (ICAs). Those with positive ICAs had intravenous and oral glucose tolerance tests (IVGTTs and OGTTs) and were randomized into one of two prevention trials. Throughout the DPT-1 parenteral and oral insulin study, 246 people were diagnosed with type 1 diabetes. RESULTS: Of the 246 subjects diagnosed with diabetes, 218 had data regarding the presence of symptoms, and 138 (63.3%) reported no symptoms suggestive of diabetes. Eight subjects (3.67%) presented with ketosis. Subjects presented with a mean ± SD A1C of 6.41 ± 1.15%. At diagnosis, 90 subjects (50.8%) had A1C in the normal range (<6.2%). OGTT data at the time of diagnosis indicate that 35.4% had a glucose result of <100 mg/dl at 0 min. CONCLUSIONS: The majority of subjects diagnosed with type 1 diabetes through the DPT-1 were asymptomatic at onset and had normal fasting glucose and A1C levels. This suggests that intermittent screening (IA followed by OGTT) may allow diagnosis of diabetes before severe metabolic decompensation. Screening with A1C will miss identifying many of the subjects with newly diagnosed type 1 diabetes in this cohort.Keywords
This publication has 24 references indexed in Scilit:
- The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetesProceedings of the National Academy of Sciences of the United States of America, 2007
- Diabetic Ketoacidosis in Infants, Children, and AdolescentsDiabetes Care, 2006
- Diabetic Ketoacidosis in Infants, Children, and Adolescents: A consensus statement from the American Diabetes AssociationDiabetes Care, 2006
- Patterns of Metabolic Progression to Type 1 Diabetes in the Diabetes Prevention Trial–Type 1Diabetes Care, 2006
- Effects of Oral Insulin in Relatives of Patients With Type 1 DiabetesDiabetes Care, 2005
- European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society Consensus Statement on Diabetic Ketoacidosis in Children and AdolescentsPediatrics, 2004
- β-Cell Function and the Development of Diabetes-Related Complications in the Diabetes Control and Complications TrialDiabetes Care, 2003
- Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group.Archives of Disease in Childhood, 1996
- Homogeneity in Pattern of Decline of β-Cell Function in IDDM: Prospective study of 204 consecutive cases followed for 7.4 yrDiabetes Care, 1992
- Clinical and Laboratory Features of Type 1 Diabetic Children at the Time of DiagnosisDiabetic Medicine, 1992